Activation of Arterial Wall Dendritic Cells and Breakdown of Self-tolerance in Giant Cell Arteritis

Journal of Experimental Medicine

Volumn 199, Issue 2, 2004, Pages 173-183

  Ma Krupa, Wei ^a   Jeon, Myung Shin ^a   Spoerl, Silvia ^a   Tedder, Thomas F ^b   Goronzy, Jörg J ^a   Weyand, Cornelia M ^a,c  

^a MAYO CLINIC   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Pathogenesis; Polymyalgia rheumatica; T cells; Toll like receptors; Vasculitis

Indexed keywords

CD83 ANTIGEN; CHEMOKINE; HLA ANTIGEN CLASS 2; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; SECONDARY LYMPHOID TISSUE CHEMOKINE; UNCLASSIFIED DRUG;

ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTERY WALL; ARTICLE; CELL ACTIVATION; CELL MATURATION; CHIMERA; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; GIANT CELL ARTERITIS; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; SCID MOUSE; TEMPORAL ARTERY; TUNICA MEDIA;

ADOPTIVE TRANSFER; ANIMALS; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CHIMERA; DENDRITIC CELLS; DNA PRIMERS; HUMANS; MICE; MICE, SCID; SELF TOLERANCE; TEMPORAL ARTERITIS; TRANSPLANTATION, HETEROLOGOUS;

EID: 1642459098     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20030850     Document Type: Article

References (52)

1. Weyand, C.M., and J.J. Goronzy. 2003. Vasculitis of medium- and large-size arteries. N. Engl. J. Med. 349:160-169.
2. Weyand, C.M. 2000. The Dunlop-Dottridge lecture: the pathogenesis of giant cell arteritis. J. Rheumatol. 27:517-522.
3. Hunder, G.G., and R.M. Valente. 2002. Giant cell arteritis: clinical aspects. In Inflammatory Diseases of Blood Vessels. G.S. Hoffman and C.M. Weyand, editors. Marcel Dekker, New York. 425-441.
4. Björnsson, J. 2002. Histopathology of primary vasculitic disorders. In Inflammatory Diseases of Blood Vessels. G.S. Hoffman and C.M. Weyand, editors. Marcel Dekker, New York. 255-265.
5. Weyand, C.M., J. Schonberger, U. Oppitz, N.N. Hunder, K.C. Hicok, and J.J. Goronzy. 1994. Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes. J. Exp. Med. 179:951-960.
6. Weyand, C.M., K.C. Hicok, G.G. Hunder, and J.J. Goronzy. 1994. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann. Intern. Med. 121:484-491.
7. Wagner, A.D., J. Bjornsson, G.B. Bartley, J.J. Goronzy, and C.M. Weyand. 1996. Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology. Am. J. Pathol. 148:1925-1933.
8. Weyand, C.M., A.D. Wagner, J. Bjornsson, and J.J. Goronzy. 1996. Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. J. Clin. Invest. 98:1642-1649.
9. Rittner, H.L., M. Kaiser, A. Brack, L.I. Szweda, J.J. Goronzy, and C.M. Weyand. 1999. Tissue-destructive macrophages in giant cell arteritis. Circ. Res. 84:1050-1058.
10. Rittner, H.L., V. Hafner, P.A. Klimiuk, L.I. Szweda, J.J. Goronzy, and C.M. Weyand. 1999. Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J. Clin. Invest. 103:1007-1013.
11. Kaiser, M., C.M. Weyand, J. Bjornsson, and J.J. Goronzy. 1998. Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis. Arthritis Rheum. 41:623-633.
12. Kaiser, M., B. Younge, J. Bjornsson, J.J. Goronzy, and C.M. Weyand. 1999. Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. Am. J. Pathol. 155:765-774.
13. Borkowski, A., B.R. Younge, L. Szweda, B. Mock, J. Bjornsson, K. Moeller, J.J. Goronzy, and C.M. Weyand. 2002. Reactive nitrogen intermediates in giant cell arteritis: selective nitration of neocapillaries. Am. J. Pathol. 161:115-123.
14. Weyand, C.M., N. Tetzlaff, J. Bjornsson, A. Brack, B. Younge, and J.J. Goronzy. 1997. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum. 40:19-26.
15. Krupa, W.M., M. Dewan, M.S. Jeon, P.J. Kurtin, B.R. Younge, J.J. Goronzy, and C.M. Weyand. 2002. Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis. Am. J. Pathol. 161:1815-1823.
16. Weyand, C.M., and J.J. Goronzy. 2000. Pathogenic principles in giant cell arteritis. Int. J. Cardiol. 75(Suppl.):S9-S15.
17. Weyand, C.M., J.W. Fulbright, J.M. Evans, G.G. Hunder, and J.J. Goronzy. 1999. Corticosteroid requirements in polymyalgia rheumatica. Arch. Intern. Med. 159:577-584.
18. Zhou, L.J., R. Schwarting, H.M. Smith, and T.F. Tedder. 1992. A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J. Immunol. 149:735-742.
19. Zhou, L.J., and T.F. Tedder. 1995. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154:3821-3835.
20. Kang, Y.M., X. Zhang, U.G. Wagner, H. Yang, R.D. Beckenbaugh, P.J. Kurtin, J.J. Goronzy, and C.M. Weyand. 2002. CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J. Exp. Med. 195:1325-1336.
21. Weyand, C.M., C. Xie, and J.J. Goronzy. 1992. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J. Clin. Invest. 89: 2033-2039.
22. Brack, A., H.L. Rittner, B.R. Younge, C. Kaltschmidt, C.M. Weyand, and J.J. Goronzy. 1997. Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras. J. Clin. Invest. 99:2842-2850.
23. Brack, A., A. Geisler, V.M. Martinez-Taboada, B.R. Younge, J.J. Goronzy, and C.M. Weyand. 1997. Giant cell vasculitis is a T cell-dependent disease. Mol. Med. 3:530-543.
24. Goronzy, J.J., C. Xie, W. Hu, S.K. Lundy, and C.M. Weyand. 1993. Restrictions in the repertoire of allospecific T cells. Contribution of the alpha-helical sequence polymorphism of HLA-DR molecules. J. Immunol. 151:825-836.
25. Kadowaki, N., S. Ho, S. Antonenko, R.W. Malefyt, R.A. Kastelein, F. Bazan, and Y.J. Liu. 2001. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194: 863-869.
26. Johansen, J.S., B. Baslund, C. Garbarsch, M. Hansen, M. Stoltenberg, I. Lorenzen, and P.A. Price. 1999. YKL-40 in giant cells and macrophages from patients with giant cell arteritis. Arthritis Rheum. 42:2624-2630.
27. Lau, A.H., and A.W. Thomson. 2003. Dendritic cells and immune regulation in the liver. Gut. 52:307-314.
28. Thomson, A.W., P.J. O'Connell, R.J. Steptoe, and L. Lu. 2002. Immunobiology of liver dendritic cells. Immunol. Cell Biol. 80:65-73.
29. Steinman, R.M., D. Hawiger, and M.C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:685-711.
30. + T cell tolerance. J. Exp. Med. 196:1627-1638.
31. Steinman, R.M., and M.C. Nussenzweig. 2002. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA. 99:351-358.
32. Liu, K., T. Iyoda, M. Saternus, Y. Kimura, K. Inaba, and R.M. Steinman. 2002. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196:1091-1097.
33. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:1213-1222.
34. Dhodapkar, M.V., R.M. Steinman, J. Krasovsky, C. Munz, and N. Bhardwaj. 2001. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193:233-238.
35. Stein-Streilein, J., and J.W. Streilein. 2002. Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy. Int. Rev. Immunol. 21:123-152.
36. Shamaei-Tousi, A., O. Collin, A. Bergh, and S. Bergstrom. 2001. Testicular damage by microcirculatory disruption and colonization of an immune-privileged site during Borrelia crocidurae infection. J. Exp. Med. 193:995-1004.
37. Sallusto, F., and A. Lanzavecchia. 2000. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol. Rev. 177:134-140.
38. Inaba, K., S. Turley, T. Iyoda, F. Yamaide, S. Shimoyama, C. Reis e Sousa, R.N. Germain, I. Mellman, and R.M. Steinman. 2000. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191:927-936.
39. Randolph, G.J. 2002. Is maturation required for Langerhans cell migration? J. Exp. Med. 196:413-416.
40. Cid, M.C., E. Campo, G. Ercilla, A. Palacin, J. Vilaseca, J. Villalta, and M. Ingelmo. 1989. Immunohistochemical analysis of lymphoid and macrophage cell subsets and their immunologic activation markers in temporal arteritis. Influence of corticosteroid treatment. Arthritis Rheum. 32:884-893.
41. Schmidt, W.A., and E. Gromnica-Ihle. 2002. Incidence of temporal arteritis in patients with polymyalgia rheumatica: a prospective study using colour Doppler ultrasonography of the temporal arteries. Rheumatology. 41:46-52.
42. Martinez-Taboada, V., N.N. Hunder, G.G. Hunder, C.M. Weyand, and J.J. Goronzy. 1996. Recognition of tissue residing antigen by T cells in vasculitic lesions of giant cell arteritis. J. Mol. Med. 74:695-703.
43. Rimenti, G., F. Blasi, R. Cosentini, O. Moling, R. Pristera, P. Tarsia, C. Vedovelli, and P. Mian. 2000. Temporal arteritis associated with Chlamydia pneumoniae DNA detected in an artery specimen. J. Rheumatol. 27:2718-2720.
44. Elling, P., A.T. Olsson, and H. Elling. 1996. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection. J. Rheumatol. 23:112-119.
45. Mitchell, B.M., and R.L. Font. 2001. Detection of varicella zoster virus DNA in some patients with giant cell arteritis. Invest. Ophthalmol. Vis. Sci. 42:2572-2577.
46. Nordborg, C., E. Nordborg, V. Petursdottir, J. LaGuardia, R. Mahalingam, M. Wellish, and D.H. Gilden. 1998. Search for varicella zoster virus in giant cell arteritis. Ann. Neurol. 44: 413-414.
47. Helweg-Larsen, J., B. Tarp, N. Obel, and B. Baslund. 2002. No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology. 41:445-449.
48. Regan, M.J., B.J. Wood, Y.H. Hsieh, M.L. Theodore, T.C. Quinn, D.B. Hellmann, W.R. Green, C.A. Gaydos, and J.H. Stone. 2002. Temporal arteritis and Chlamydia pneumoniae: failure to detect the organism by polymerase chain reaction in ninety cases and ninety controls. Arthritis Rheum. 46:1056-1060.
49. Triantafilou, M., and K. Triantafilou. 2002. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 23:301-304.
50. Soler-Rodriguez, A.M., H. Zhang, H.S. Lichenstein, N. Qureshi, D.W. Niesel, S.E. Crowe, J.W. Peterson, and G.R. Klimpel. 2000. Neutrophil activation by bacterial lipoprotein versus lipopolysaccharide: differential requirements for serum and CD14. J. Immunol. 164:2674-2683.
51. Weyand, C.M., J.W. Fulbright, G.G. Hunder, J.M. Evans, and J.J. Goronzy. 2000. Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity. Arthritis Rheum. 43:1041-1048.
52. Weyand, C.M., M. Kaiser, H. Yang, B. Younge, and J.J. Goronzy. 2002. Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis Rheum. 46:457-466.